Moreover, treatment of APL cells with therapeutic doses of all-trans retinoic acid (ATRA) induces transcriptional activation by PML-RARα, followed by PML-RARα degradation and rapid and effective APL blast differentiation and leukemia de-bulking (Ablain & de The, 2011). Here, PML is linked to leukemia.